KindlyMD Approved for Options Trading on Nasdaq
KindlyMD (NASDAQ:NAKA), a healthcare services provider and Bitcoin treasury vehicle, has received approval for options trading on the Nasdaq Options Market. The options will begin trading under the symbol "NAKA" with various expiration dates and strike prices.
The company, formed in 2019, combines healthcare data analytics with Bitcoin treasury management through its August 2025 merger with Nakamoto Holdings. KindlyMD focuses on value-based care, personalized medical services, and reducing opioid use while maintaining a Bitcoin treasury strategy.
This options trading approval represents a significant milestone for KindlyMD, expanding its capital markets presence and offering investors additional tools for risk management and position leverage.
KindlyMD (NASDAQ:NAKA), fornitore di servizi sanitari e veicolo di tesoreria in Bitcoin, ha ottenuto l'autorizzazione per la negoziazione di opzioni sul Nasdaq Options Market. Le opzioni inizieranno a essere scambiate con il simbolo "NAKA" e saranno disponibili con diverse scadenze e prezzi di esercizio.
Fondata nel 2019, la società integra l'analisi dei dati sanitari con la gestione di una tesoreria in Bitcoin tramite la fusione con Nakamoto Holdings prevista per agosto 2025. KindlyMD è focalizzata su cure basate sul valore, servizi medici personalizzati e la riduzione dell'uso di oppioidi, mantenendo al contempo una strategia di tesoreria in Bitcoin.
Questa approvazione per la negoziazione di opzioni rappresenta un importante traguardo per KindlyMD, ampliando la sua presenza nei mercati dei capitali e offrendo agli investitori strumenti aggiuntivi per la gestione del rischio e la leva sulle posizioni.
KindlyMD (NASDAQ:NAKA), proveedor de servicios sanitarios y vehículo de tesorería en Bitcoin, ha recibido la aprobación para la negociación de opciones en el Nasdaq Options Market. Las opciones comenzarán a negociarse bajo el símbolo "NAKA" con distintas fechas de vencimiento y precios de ejercicio.
La compañía, fundada en 2019, combina el análisis de datos sanitarios con la gestión de una tesorería en Bitcoin mediante la fusión con Nakamoto Holdings prevista para agosto de 2025. KindlyMD se centra en la atención basada en el valor, servicios médicos personalizados y la reducción del uso de opioides, manteniendo a la vez una estrategia de tesorería en Bitcoin.
La aprobación para negociar opciones marca un hito relevante para KindlyMD, ampliando su presencia en los mercados de capital y ofreciendo a los inversores herramientas adicionales para gestionar riesgos y apalancar posiciones.
KindlyMD (NASDAQ:NAKA)는 헬스케어 서비스 제공업체이자 비트코인 재무관리 수단으로서 나스닥 옵션 마켓(Nasdaq Options Market)에서 옵션 거래 승인을 받았습니다. 해당 옵션은 기호 "NAKA"로 상장되며 다양한 만기일과 행사가격으로 거래됩니다.
2019년에 설립된 이 회사는 2025년 8월 예정된 Nakamoto Holdings와의 합병을 통해 헬스케어 데이터 분석과 비트코인 재무 관리를 결합합니다. KindlyMD는 가치 기반 의료, 개인 맞춤형 의료 서비스, 오피오이드 사용 감소에 중점을 두면서 비트코인 재무 전략을 유지합니다.
이번 옵션 거래 승인으로 KindlyMD는 자본시장 내 입지를 넓히게 되었으며, 투자자들에게 리스크 관리와 포지션 레버리지에 대한 추가 수단을 제공하게 되었습니다.
KindlyMD (NASDAQ:NAKA), prestataire de services de santé et véhicule de trésorerie en Bitcoin, a obtenu l'autorisation de négocier des options sur le Nasdaq Options Market. Les options commenceront à être négociées sous le symbole « NAKA » avec diverses dates d'échéance et prix d'exercice.
Créée en 2019, la société associe l'analyse des données de santé à la gestion d'une trésorerie en Bitcoin via la fusion avec Nakamoto Holdings prévue en août 2025. KindlyMD se concentre sur les soins fondés sur la valeur, les services médicaux personnalisés et la réduction de l'utilisation d'opioïdes, tout en maintenant une stratégie de trésorerie en Bitcoin.
Cette approbation pour le trading d'options constitue une étape importante pour KindlyMD, renforçant sa présence sur les marchés de capitaux et offrant aux investisseurs des outils supplémentaires pour la gestion du risque et l'effet de levier des positions.
KindlyMD (NASDAQ:NAKA), ein Anbieter von Gesundheitsdienstleistungen und zugleich Bitcoin-Treasury-Fahrzeug, hat die Zulassung für den Optionshandel am Nasdaq Options Market erhalten. Die Optionen werden unter dem Symbol "NAKA" gehandelt und sind mit verschiedenen Verfallsterminen und Ausübungspreisen verfügbar.
Das 2019 gegründete Unternehmen kombiniert Gesundheitsdaten-Analytik mit Bitcoin-Treasury-Management durch die für August 2025 geplante Fusion mit Nakamoto Holdings. KindlyMD legt den Schwerpunkt auf wertorientierte Versorgung, personalisierte medizinische Dienstleistungen und die Reduzierung des Opioid-Einsatzes, während es seine Bitcoin-Treasury-Strategie beibehält.
Die Zulassung zum Optionshandel stellt einen wichtigen Meilenstein für KindlyMD dar: Sie erweitert die Präsenz an den Kapitalmärkten und bietet Investoren zusätzliche Instrumente zur Risikosteuerung und Hebelung von Positionen.
- Introduction of options trading enhances market accessibility and risk management tools for investors
- Strategic merger with Nakamoto Holdings creates diversified business model combining healthcare and Bitcoin treasury management
- Expanded capital markets presence through Nasdaq options listing
- Exposure to Bitcoin market volatility and cryptocurrency risks
- Complex business model mixing healthcare operations with Bitcoin treasury management may increase operational risks
- Subject to significant regulatory uncertainties in both healthcare and cryptocurrency sectors
Insights
Nasdaq options approval enhances KindlyMD's market presence, offering investors additional trading tools while signaling market maturity.
The approval of options trading for KindlyMD (NASDAQ: NAKA) represents a significant milestone in the company's capital markets evolution. Options trading approval typically occurs when a stock has demonstrated sufficient liquidity, market capitalization, and trading volume to support derivatives trading - indicating the market's growing confidence in NAKA as an established security.
This development delivers three key benefits to the company and its shareholders:
- Enhanced liquidity - Options trading typically attracts additional market participants, potentially reducing bid-ask spreads and improving overall trading efficiency
- Expanded hedging capabilities - Institutional investors can now implement more sophisticated risk management strategies around their NAKA holdings
- Increased market visibility - Options market activity often draws additional analyst coverage and trader attention
The timing is particularly noteworthy as KindlyMD completed its merger with Nakamoto Holdings just last month (August 2025). This rapid progression to options eligibility suggests strong initial market reception to the combined entity's unique business model that bridges healthcare services with Bitcoin treasury management.
From a technical perspective, the availability of standardized strike prices and expiration dates will create a more robust price discovery mechanism and potentially reduce volatility through enhanced market efficiency. For existing shareholders, this represents a meaningful step in KindlyMD's market maturation that typically correlates with improved institutional accessibility.
SALT LAKE CITY, UT / ACCESS Newswire / September 10, 2025 / KindlyMD, Inc. (NASDAQ:NAKA) ("KindlyMD" or "the Company"), a provider of integrated healthcare services and a Bitcoin treasury vehicle via its subsidiary Nakamoto Holdings ("Nakamoto"), today announced that options on its common stock have been approved for trading tomorrow on the Nasdaq Options Market ("Nasdaq").
Trading of KindlyMD options will commence under the ticker symbol "NAKA" and includes a range of standard expiration dates and strike prices. The introduction of listed options is expected to broaden investor visibility and provide shareholders with additional tools to manage risk, leverage positions, and engage with KindlyMD's long-term growth strategy.
"The commencement of options trading on the Nasdaq marks another important milestone for KindlyMD, further enhancing our capital markets presence and providing shareholders with greater flexibility in how they invest in the Nakamoto story," said David Bailey, Chairman and CEO of KindlyMD.
Institutional and retail investors can access NAKA options through major brokerage platforms and trading networks that support equity options on the Nasdaq exchange.
About KindlyMD
KindlyMD® is a patient-first and healthcare data company redefining value-based care and patient-centered medical services. Formed in 2019, KindlyMD leverages data analysis to deliver evidence-based, personalized solutions in order to reduce opioid use, improve health outcomes faster, and provide value based, algorithmic guidance on the use of alternative medicine in healthcare. In August 2025, KindlyMD completed its merger with Nakamoto Holdings Inc., a Bitcoin-native holding company. This strategic partnership formed a public Bitcoin treasury strategy that unites KindlyMD's healthcare expertise with Nakamoto's vision of integrating Bitcoin into global capital markets, creating a diversified entity focused on both healthcare innovation and Bitcoin treasury management.
Forward-Looking Statements
All statements, other than statements of historical fact, included in this press release that address activities, events or developments that that the Company expects, believes or anticipates will or may occur in the future are forward-looking statements, as defined under U.S. federal securities laws, related to the Company. Forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts and often include statements about our future operations, business strategies, plans, objectives, expectations, intentions, goals, projections, prospects, future events, or performance, as well as underlying assumptions. These statements-covering matters such as expectations, plans, strategic outlooks, financial projections, market conditions, regulatory environments, Bitcoin-related strategies, Bitcoin treasury management activities, and the Company's anticipated holding of Bitcoin as part of its corporate treasury are inherently uncertain and involve numerous assumptions and risks.
Forward-looking terms used may include, but are not limited to, "estimate," "project," "predict," "believe," "expect," "anticipate," "potential," "create," "intend," "could," "would," "may," "plan," "will," "guidance," "look," "goal," "future," "build," "focus," "continue," "strive," "allow," "seek," "aim," "target," or the negative of such terms or other variations thereof and words and terms of similar substance used in connection with any discussion of future plans, actions, or events identify forward-looking statements and similar expressions. However, the absence of these words does not mean that the statements are not forward-looking. These forward-looking statements include, but are not limited to, descriptions of the Company and its operations, strategies and plans, integration, debt levels and leverage ratio, capital expenditures, cash flows and anticipated uses thereof, including the purchase, custody, and potential sale or other use of Bitcoin, synergies, opportunities and anticipated future performance, including the management team and board of directors of the Company. These statements may also relate to broader macroeconomic trends, industry developments, technology adoption, competitive positioning, market expansion, product launches, research and development efforts, acquisitions or dispositions, legal or regulatory developments, and other initiatives that could affect our future business performance. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements included in this communication. These include risks relating to Bitcoin market volatility, cybersecurity and custody of digital assets, potential changes in laws or accounting standards relating to cryptocurrency, and regulatory developments affecting Bitcoin or other digital assets, as well as the risk that changes in the Company's capital structure and governance could have adverse effects on the market value of its securities; the ability of the Company to retain customers and retain and hire key personnel and maintain relationships with their suppliers and customers and on the Company operating results and business generally; the risk that the Company may be unable to reduce expenses or access financing or liquidity; the impact of any related economic downturn; the risk of changes in governmental regulations or enforcement practices; adverse impacts from geopolitical events, health crises, supply chain disruptions, changes to laws or accounting standards, cybersecurity threats or data breaches, intellectual property disputes, competitive pressures, or changes in consumer behavior; and other important factors that could cause actual results to differ materially from those projected. All such factors are difficult to predict and are beyond the Company's control, including those detailed in the Company's Annual Reports on Form 10-K, Quarterly Reports on Form 10- Q, Current Reports on Form 8-K, and such other documents of the Company filed, or to be filed, with the SEC that are or will be available on the Company's website at www.kindlymd.com and on the website of the SEC at www.sec.gov. All forward-looking statements are based on assumptions that the Company believes to be reasonable but that may not prove to be accurate. Any forward-looking statement speaks only as of the date on which such statement is made, and the Company does not undertake any obligation to correct or update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by applicable law. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Nothing contained herein constitutes an offer to buy or sell securities of the Company or any other party, nor does it constitute a solicitation of any proxy or vote.
Contacts
Investor Relations:
Valter Pinto, Managing Director
KCSA Strategic Communications
(212) 896-1254
KindlyMD@KCSA.com
Media:
Carissa Felger / Sam Cohen
Gasthalter & Co.
(212) 257-4170
Nakamoto@gasthalter.com
SOURCE: KindlyMD, Inc.
View the original press release on ACCESS Newswire
FAQ
When will KindlyMD (NAKA) options begin trading on Nasdaq?
What was KindlyMD's merger with Nakamoto Holdings in August 2025?
How can investors trade KindlyMD (NAKA) options?
What is KindlyMD's main business focus?
What are the main risks associated with KindlyMD's business model?
